{"id":318467,"date":"2026-10-21T10:10:10","date_gmt":"2026-10-21T04:40:10","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=318467"},"modified":"2026-10-21T10:10:10","modified_gmt":"2026-10-21T04:40:10","slug":"steady-5-year-gainer-stocks-to-watch-multibagger-potential","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/steady-5-year-gainer-stocks-to-watch-multibagger-potential\/","title":{"rendered":"4 Top Steady 5-Year Gainer Stocks to Watch for Future Multibagger Potential: Divi&#8217;s Labs, Apollo Hospitals, Lodha Developers and Oberoi Realty"},"content":{"rendered":"<p style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;font-style:italic;\"><em>Divi&#8217;s Labs Rs 9,087. Apollo Hospitals Rs 7,700. Lodha Developers Rs 1,030. Oberoi Realty Rs 1,676.40. Market caps from Rs 61,940 crore to Rs 2.40 lakh crore. Data as of 20 Oct 2026.<\/em><\/p>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">Divi&#8217;s Labs, Apollo Hospitals, Lodha Developers and Oberoi Realty are the 4 picks in this steady 5-year gainer stocks watchlist, with market caps between Rs 61,940 crore and Rs 2.40 lakh crore. Divi&#8217;s Labs stands out for the largest market cap at Rs 2,39,982 crore, while Apollo Hospitals offers the highest return on equity at 20.48%. PE ratios run from 23.56 to 82.05, so compare each one with its industry PE before investing. All figures are as of 20 October 2026.<\/p>\n<\/p><\/div>\n<p>Steady 5-year gainer stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Divi&#8217;s Labs, Apollo Hospitals, Lodha Developers and Oberoi Realty meet that test, with market caps from Rs 61,940 crore to Rs 2.40 lakh crore and Divi&#8217;s Labs offering the largest market cap at Rs 2,39,982 crore. Each of these large companies has gained between 50 and 100 per cent in five years, with profit growing along the way.<\/p>\n<p>This list covers large companies with five-year price gains between 50 and 100 per cent, rising profit and complete, verifiable financials, ranked by market capitalisation. Not every name here is a largecap, so the list takes the leading companies of the sector by market capitalisation. Investors screening steady 5-year gainer stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 20 October 2026 and are drawn from NSE and BSE data and company filings.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=steady-year-gainer-stocks\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/steady-5-year-gainer-stocks-to-watch-multibagger-potential\/#What_Are_Steady_5-Year_Gainer_Stocks_and_Why_Do_They_Attract_Multibagger_Interest\" title=\"What Are Steady 5-Year Gainer Stocks and Why Do They Attract Multibagger Interest?\">What Are Steady 5-Year Gainer Stocks and Why Do They Attract Multibagger Interest?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/steady-5-year-gainer-stocks-to-watch-multibagger-potential\/#Steady_5-Year_Gainer_Stocks_at_a_Glance_Price_Market_Cap_PE_and_ROE\" title=\"Steady 5-Year Gainer Stocks at a Glance: Price, Market Cap, PE and ROE\">Steady 5-Year Gainer Stocks at a Glance: Price, Market Cap, PE and ROE<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/steady-5-year-gainer-stocks-to-watch-multibagger-potential\/#Divis_Labs_Debt-to-Equity_of_000\" title=\"Divi&#8217;s Labs: Debt-to-Equity of 0.00\">Divi&#8217;s Labs: Debt-to-Equity of 0.00<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/steady-5-year-gainer-stocks-to-watch-multibagger-potential\/#Apollo_Hospitals_Return_on_Equity_of_2048\" title=\"Apollo Hospitals: Return on Equity of 20.48%\">Apollo Hospitals: Return on Equity of 20.48%<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/steady-5-year-gainer-stocks-to-watch-multibagger-potential\/#Lodha_Developers_2980_Profit_CAGR_Since_FY22\" title=\"Lodha Developers: 29.80% Profit CAGR Since FY22\">Lodha Developers: 29.80% Profit CAGR Since FY22<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/steady-5-year-gainer-stocks-to-watch-multibagger-potential\/#Oberoi_Realty_2440_Profit_CAGR_Since_FY22\" title=\"Oberoi Realty: 24.40% Profit CAGR Since FY22\">Oberoi Realty: 24.40% Profit CAGR Since FY22<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/steady-5-year-gainer-stocks-to-watch-multibagger-potential\/#Steady_5-Year_Gainer_Stocks_Financial_Comparison_on_Growth_and_Margins\" title=\"Steady 5-Year Gainer Stocks: Financial Comparison on Growth and Margins\">Steady 5-Year Gainer Stocks: Financial Comparison on Growth and Margins<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/steady-5-year-gainer-stocks-to-watch-multibagger-potential\/#Institutional_Holding_in_Divis_Labs_Apollo_Hospitals_Lodha_Developers_and_Oberoi_Realty\" title=\"Institutional Holding in Divi&#8217;s Labs, Apollo Hospitals, Lodha Developers and Oberoi Realty\">Institutional Holding in Divi&#8217;s Labs, Apollo Hospitals, Lodha Developers and Oberoi Realty<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/steady-5-year-gainer-stocks-to-watch-multibagger-potential\/#Risks_to_Weigh_in_Steady_5-Year_Gainer_Stocks\" title=\"Risks to Weigh in Steady 5-Year Gainer Stocks\">Risks to Weigh in Steady 5-Year Gainer Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/steady-5-year-gainer-stocks-to-watch-multibagger-potential\/#How_to_Choose_Between_Steady_5-Year_Gainer_Stocks\" title=\"How to Choose Between Steady 5-Year Gainer Stocks\">How to Choose Between Steady 5-Year Gainer Stocks<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/steady-5-year-gainer-stocks-to-watch-multibagger-potential\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/steady-5-year-gainer-stocks-to-watch-multibagger-potential\/#Frequently_Asked_Questions_on_Steady_5-Year_Gainer_Stocks_to_Watch\" title=\"Frequently Asked Questions on Steady 5-Year Gainer Stocks to Watch\">Frequently Asked Questions on Steady 5-Year Gainer Stocks to Watch<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/steady-5-year-gainer-stocks-to-watch-multibagger-potential\/#Which_are_the_best_steady_5-year_gainer_stocks_to_watch_for_multibagger_potential\" title=\"Which are the best steady 5-year gainer stocks to watch for multibagger potential?\">Which are the best steady 5-year gainer stocks to watch for multibagger potential?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/steady-5-year-gainer-stocks-to-watch-multibagger-potential\/#Is_Apollo_Hospitals_a_good_stock_for_long-term_investors\" title=\"Is Apollo Hospitals a good stock for long-term investors?\">Is Apollo Hospitals a good stock for long-term investors?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/steady-5-year-gainer-stocks-to-watch-multibagger-potential\/#Can_Lodha_Developers_become_a_multibagger_from_here\" title=\"Can Lodha Developers become a multibagger from here?\">Can Lodha Developers become a multibagger from here?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/steady-5-year-gainer-stocks-to-watch-multibagger-potential\/#What_is_the_market_cap_of_Divis_Labs_Apollo_Hospitals_Lodha_Developers_and_Oberoi_Realty\" title=\"What is the market cap of Divi&#8217;s Labs, Apollo Hospitals, Lodha Developers and Oberoi Realty?\">What is the market cap of Divi&#8217;s Labs, Apollo Hospitals, Lodha Developers and Oberoi Realty?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/steady-5-year-gainer-stocks-to-watch-multibagger-potential\/#What_are_the_risks_of_investing_in_steady_5-year_gainer_stocks\" title=\"What are the risks of investing in steady 5-year gainer stocks?\">What are the risks of investing in steady 5-year gainer stocks?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/steady-5-year-gainer-stocks-to-watch-multibagger-potential\/#Why_is_Divis_Labs_trading_at_a_PE_of_8205\" title=\"Why is Divi&#8217;s Labs trading at a PE of 82.05?\">Why is Divi&#8217;s Labs trading at a PE of 82.05?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/steady-5-year-gainer-stocks-to-watch-multibagger-potential\/#How_much_do_institutions_hold_in_Divis_Labs_Apollo_Hospitals_Lodha_Developers_and_Oberoi_Realty\" title=\"How much do institutions hold in Divi&#8217;s Labs, Apollo Hospitals, Lodha Developers and Oberoi Realty?\">How much do institutions hold in Divi&#8217;s Labs, Apollo Hospitals, Lodha Developers and Oberoi Realty?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"What_Are_Steady_5-Year_Gainer_Stocks_and_Why_Do_They_Attract_Multibagger_Interest\"><\/span><strong>What Are Steady 5-Year Gainer Stocks and Why Do They Attract Multibagger Interest?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Steady 5-year gainer stocks are shares that have grown at a measured pace rather than in sharp bursts. The four here cover pharmaceutical ingredients, hospitals and residential real estate.<\/p>\n<p>Steady gains backed by rising profit often suit investors who prefer a smoother path. Among steady 5-year gainer stocks, companies with strong earnings growth are the ones investors compare in steady 5-year gainer stocks. This guide looks at steady 5-year gainer stocks using FY26 results and the latest quarterly numbers. Every one of steady 5-year gainer stocks below has complete, verifiable data.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Steady_5-Year_Gainer_Stocks_at_a_Glance_Price_Market_Cap_PE_and_ROE\"><\/span><strong>Steady 5-Year Gainer Stocks at a Glance: Price, Market Cap, PE and ROE<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Prices are closing prices as of 20 October 2026. Oberoi Realty has the lowest PE of the group at 23.56, while Apollo Hospitals posts the highest return on equity at 20.48%.<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Stock<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">CMP (Rs)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Market Cap (Rs Cr)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">PE<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Industry PE<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">ROE<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Debt to Equity<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">52-Week Range (Rs)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/divislab\/divi's-laboratories-ltd-share-price-today\">Divi&#8217;s Laboratories<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">9,087<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">2,39,982<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">82.05<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">36.42<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">15.32%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">0.00<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">5,647.50 to 9,740.00<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/apollohosp\/apollo-hospitals-enterprise-ltd-share-price-today\">Apollo Hospitals Enterprise<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">7,700<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,14,101<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">52.53<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">60.75<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">20.48%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">0.90<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">6,696.50 to 9,070.50<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/lodha\/macrotech-developers-ltd-share-price-today\">Lodha Developers<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,030<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,06,038<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">25.68<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">31.94<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">14.72%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">0.42<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">650.80 to 1,344.95<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/oberoirlty\/oberoi-realty-ltd-share-price-today\">Oberoi Realty<\/a><\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,676.40<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">61,940<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">23.56<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">31.94<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">13.99%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">0.16<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">1,391.20 to 1,986.10<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Divis_Labs_Debt-to-Equity_of_000\"><\/span><strong>Divi&#8217;s Labs: Debt-to-Equity of 0.00<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Divi&#8217;s Laboratories makes active pharmaceutical ingredients and intermediates and runs a large custom synthesis business for global drug companies. It reported FY26 revenue of Rs 11,067 crore, up 13.95% year on year, and net profit of Rs 2,568 crore, up 17.21%. Revenue has compounded at 5.09% a year since FY22. Operating margin was 36.70% in FY26. The debt-to-equity ratio is 0.00, which keeps interest costs low.<\/p>\n<p>In the June 2026 quarter, revenue rose 24.32% to Rs 3,144 crore and net profit grew 65.50% to Rs 902 crore. The share price has gained 71.04% over five years and 38.43% over the past year. Foreign investors raised their holding from 19.39% in September 2025 to 20.38% in September 2026. The stock trades at a PE of 82.05 against an industry PE of 36.42, with a return on equity of 15.32%.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Apollo_Hospitals_Return_on_Equity_of_2048\"><\/span><strong>Apollo Hospitals: Return on Equity of 20.48%<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Apollo Hospitals Enterprise runs one of India&#8217;s largest hospital networks and also operates pharmacies and a digital health platform. It reported FY26 revenue of Rs 25,420.10 crore, up 15.58% year on year, and net profit of Rs 2,002.70 crore, up 33.06%. Net profit has compounded at 16.13% a year since FY22, while revenue has grown 14.59% a year. Operating margin was 15.80% in FY26.<\/p>\n<p>The stock trades at a PE of 52.53 against an industry PE of 60.75, below the sector average, with a return on equity of 20.48%. In the June 2026 quarter, revenue rose 20.57% to Rs 7,092.30 crore and net profit grew 38.41% to Rs 610.40 crore. The share price has gained 83.08% over five years. Domestic institutions raised their holding from 21.12% in September 2025 to 22.07% in September 2026.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Lodha_Developers_2980_Profit_CAGR_Since_FY22\"><\/span><strong>Lodha Developers: 29.80% Profit CAGR Since FY22<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Lodha Developers (formerly Macrotech Developers) is a leading residential developer in the Mumbai Metropolitan Region, with projects in Pune and Bengaluru. It reported FY26 revenue of Rs 17,119.50 crore, up 20.82% year on year, and net profit of Rs 3,430.70 crore, up 24.00%. Net profit has compounded at 29.80% a year since FY22, while revenue has grown 15.79% a year. Operating margin was 32.23% in FY26. The debt-to-equity ratio is 0.42.<\/p>\n<p>In the June 2026 quarter, revenue rose 40.61% to Rs 5,096.70 crore and net profit grew 103.39% to Rs 1,373.10 crore. The share price has gained 78.95% over five years. Domestic institutions raised their holding from 2.20% in June 2025 to 3.57% in June 2026. The stock trades at a PE of 25.68 against an industry PE of 31.94, below the sector average, with a return on equity of 14.72%.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Oberoi_Realty_2440_Profit_CAGR_Since_FY22\"><\/span><strong>Oberoi Realty: 24.40% Profit CAGR Since FY22<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Oberoi Realty develops premium residential, office, retail and hotel projects, mainly in Mumbai. It reported FY26 revenue of Rs 6,304.27 crore, up 15.16% year on year, and net profit of Rs 2,507.43 crore, up 12.67%. Net profit has compounded at 24.40% a year since FY22, while revenue has grown 23.02% a year. Operating margin was 60.69% in FY26. The debt-to-equity ratio is 0.16.<\/p>\n<p>The stock trades at a PE of 23.56 against an industry PE of 31.94, below the sector average, with a return on equity of 13.99%. In the June 2026 quarter, revenue rose 26.79% to Rs 1,361.69 crore and net profit grew 29.02% to Rs 543.51 crore. The share price has gained 93.04% over five years. Domestic institutions raised their holding from 10.80% in June 2025 to 14.83% in June 2026.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Steady_5-Year_Gainer_Stocks_Financial_Comparison_on_Growth_and_Margins\"><\/span><strong>Steady 5-Year Gainer Stocks: Financial Comparison on Growth and Margins<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The table compares scale and growth across these steady 5-year gainer stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Stock<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Revenue (Rs Cr)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Net Profit (Rs Cr)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Revenue Growth (YoY)<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">4-Year Revenue CAGR<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Latest Quarter Revenue Growth<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Operating Margin (Latest Quarter)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Divi&#8217;s Labs<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">11,067<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">2,568<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">13.95%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">5.09%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">24.32%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">42.82%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Apollo Hospitals<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">25,420.10<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">2,002.70<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">15.58%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">14.59%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">20.57%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">16.39%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Lodha Developers<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">17,119.50<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">3,430.70<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">20.82%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">15.79%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">40.61%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">40.51%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Oberoi Realty<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">6,304.27<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">2,507.43<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">15.16%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">23.02%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">26.79%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">61.42%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live data on these steady 5-year gainer stocks<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Institutional_Holding_in_Divis_Labs_Apollo_Hospitals_Lodha_Developers_and_Oberoi_Realty\"><\/span><strong>Institutional Holding in Divi&#8217;s Labs, Apollo Hospitals, Lodha Developers and Oberoi Realty<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Institutional holding shows who is backing these steady 5-year gainer stocks alongside the promoter. The table uses the latest reported quarter for each. Apollo Hospitals has the deepest institutional backing, with FII and DII together holding 65.25% as of September 2026. Domestic institutions increased their holding over the past year in Apollo Hospitals (from 21.12% to 22.07%), Lodha Developers (from 2.20% to 3.57%) and Oberoi Realty (from 10.80% to 14.83%).<\/p>\n<table style=\"border-collapse:collapse;width:100%;margin:16px 0;\">\n<thead>\n<tr>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Stock<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Promoter<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">FII<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">DII<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Public<\/th>\n<th style=\"border:1px solid #BBBBBB;background:#1F4E79;color:#FFFFFF;padding:8px;text-align:left;\">Quarter<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Divi&#8217;s Labs<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">51.88%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">20.38%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">19.17%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">8.58%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">September 2026<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Apollo Hospitals<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">28.02%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">43.18%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">22.07%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">6.72%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">September 2026<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Lodha Developers<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">70.31%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">23.65%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">3.57%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">2.47%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">June 2026<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">Oberoi Realty<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">67.70%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">15.11%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">14.83%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">2.36%<\/td>\n<td style=\"border:1px solid #BBBBBB;padding:8px;\">June 2026<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Risks_to_Weigh_in_Steady_5-Year_Gainer_Stocks\"><\/span><strong>Risks to Weigh in Steady 5-Year Gainer Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Being careful with steady 5-year gainer stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:<\/p>\n<ul>\n<li>Past returns do not guarantee future returns.<\/li>\n<li>Sector cycles can slow growth.<\/li>\n<li><strong>Valuation:<\/strong> Divi&#8217;s Labs trades at a PE of 82.05 against an industry PE of 36.42, so earnings need to keep growing to support the price.<\/li>\n<li><strong>Concentration:<\/strong> Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"How_to_Choose_Between_Steady_5-Year_Gainer_Stocks\"><\/span><strong>How to Choose Between Steady 5-Year Gainer Stocks<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Picking from steady 5-year gainer stocks comes down to four checks, applied in order.<\/p>\n<ol>\n<li>Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.<\/li>\n<li>Compare each PE with the industry PE (31.94 to 60.75) and ask whether the growth rate justifies any gap.<\/li>\n<li>Track net profit growth, the return on equity and the five-year return in every result.<\/li>\n<li>Stagger entries across quarters and review institutional holding every reporting season.<\/li>\n<\/ol>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Divi&#8217;s Labs, Apollo Hospitals, Lodha Developers and Oberoi Realty live prices.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Among steady 5-year gainer stocks, Divi&#8217;s Labs stands out for the largest market cap at Rs 2,39,982 crore, Apollo Hospitals for the highest return on equity at 20.48%, Lodha Developers for the fastest profit growth, 29.80% a year since FY22 and Oberoi Realty for the biggest five-year price gain at 93.04%. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing steady 5-year gainer stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/p><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_Steady_5-Year_Gainer_Stocks_to_Watch\"><\/span><strong>Frequently Asked Questions on Steady 5-Year Gainer Stocks to Watch<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Which_are_the_best_steady_5-year_gainer_stocks_to_watch_for_multibagger_potential\"><\/span><strong>Which are the best steady 5-year gainer stocks to watch for multibagger potential?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Divi&#8217;s Labs, Apollo Hospitals, Lodha Developers and Oberoi Realty are the 4 names this list highlights, with market caps of Rs 2,39,982 crore, Rs 1,14,101 crore, Rs 1,06,038 crore and Rs 61,940 crore respectively. Divi&#8217;s Labs is notable for the largest market cap at Rs 2,39,982 crore. Apollo Hospitals stands out for the highest return on equity at 20.48%. Lodha Developers offers the fastest profit growth, 29.80% a year since FY22. Oberoi Realty brings the biggest five-year price gain at 93.04%. These are watchlist names for steady 5-year gainer stocks, not recommendations, so match each one to your own risk profile and time horizon.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Apollo_Hospitals_a_good_stock_for_long-term_investors\"><\/span><strong>Is Apollo Hospitals a good stock for long-term investors?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Apollo Hospitals has a return on equity of 20.48%, a PE of 52.53 against an industry PE of 60.75 and a market cap of Rs 1,14,101 crore. Net profit has compounded at 16.13% a year since FY22, and FY26 revenue rose 15.58% while June 2026 quarter net profit grew 38.41%. Long-term returns in steady 5-year gainer stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Can_Lodha_Developers_become_a_multibagger_from_here\"><\/span><strong>Can Lodha Developers become a multibagger from here?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Lodha Developers has already gained 78.95% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in steady 5-year gainer stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 29.80% a year since FY22, and FY26 revenue rose 20.82%. At a PE of 25.68 against an industry PE of 31.94, valuation should be checked against that growth before investing.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_cap_of_Divis_Labs_Apollo_Hospitals_Lodha_Developers_and_Oberoi_Realty\"><\/span><strong>What is the market cap of Divi&#8217;s Labs, Apollo Hospitals, Lodha Developers and Oberoi Realty?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> As of 20 October 2026, Divi&#8217;s Labs has a market cap of Rs 2,39,982 crore, Apollo Hospitals has a market cap of Rs 1,14,101 crore, Lodha Developers has a market cap of Rs 1,06,038 crore and Oberoi Realty has a market cap of Rs 61,940 crore. Divi&#8217;s Labs is the largest of the group. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on steady 5-year gainer stocks.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_risks_of_investing_in_steady_5-year_gainer_stocks\"><\/span><strong>What are the risks of investing in steady 5-year gainer stocks?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Divi&#8217;s Labs trades at a PE of 82.05 against an industry PE of 36.42, so earnings growth needs to hold up.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Divis_Labs_trading_at_a_PE_of_8205\"><\/span><strong>Why is Divi&#8217;s Labs trading at a PE of 82.05?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Divi&#8217;s Labs&#8217; PE of 82.05 compares with an industry PE of 36.42. The market is paying a premium for a return on equity of 15.32% and latest-quarter profit growth of 65.50%, which also means the stock is more sensitive if growth slows. Investors in steady 5-year gainer stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_do_institutions_hold_in_Divis_Labs_Apollo_Hospitals_Lodha_Developers_and_Oberoi_Realty\"><\/span><strong>How much do institutions hold in Divi&#8217;s Labs, Apollo Hospitals, Lodha Developers and Oberoi Realty?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> As of the latest reported quarter, FII and DII together hold 39.55% of Divi&#8217;s Labs (20.38% and 19.17%), 65.25% of Apollo Hospitals (43.18% and 22.07%), 27.22% of Lodha Developers (23.65% and 3.57%) and 29.94% of Oberoi Realty (15.11% and 14.83%). Rising institutional holding is a useful signal in steady 5-year gainer stocks, though it should be read with earnings trends rather than on its own.<\/p>\n<p><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Which are the best steady 5-year gainer stocks to watch for multibagger potential?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Divi's Labs, Apollo Hospitals, Lodha Developers and Oberoi Realty are the 4 names this list highlights, with market caps of Rs 2,39,982 crore, Rs 1,14,101 crore, Rs 1,06,038 crore and Rs 61,940 crore respectively. Divi's Labs is notable for the largest market cap at Rs 2,39,982 crore. Apollo Hospitals stands out for the highest return on equity at 20.48%. Lodha Developers offers the fastest profit growth, 29.80% a year since FY22. Oberoi Realty brings the biggest five-year price gain at 93.04%. These are watchlist names for steady 5-year gainer stocks, not recommendations, so match each one to your own risk profile and time horizon.\"}},{\"@type\":\"Question\",\"name\":\"Is Apollo Hospitals a good stock for long-term investors?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Apollo Hospitals has a return on equity of 20.48%, a PE of 52.53 against an industry PE of 60.75 and a market cap of Rs 1,14,101 crore. Net profit has compounded at 16.13% a year since FY22, and FY26 revenue rose 15.58% while June 2026 quarter net profit grew 38.41%. Long-term returns in steady 5-year gainer stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.\"}},{\"@type\":\"Question\",\"name\":\"Can Lodha Developers become a multibagger from here?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Lodha Developers has already gained 78.95% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in steady 5-year gainer stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 29.80% a year since FY22, and FY26 revenue rose 20.82%. At a PE of 25.68 against an industry PE of 31.94, valuation should be checked against that growth before investing.\"}},{\"@type\":\"Question\",\"name\":\"What is the market cap of Divi's Labs, Apollo Hospitals, Lodha Developers and Oberoi Realty?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"As of 20 October 2026, Divi's Labs has a market cap of Rs 2,39,982 crore, Apollo Hospitals has a market cap of Rs 1,14,101 crore, Lodha Developers has a market cap of Rs 1,06,038 crore and Oberoi Realty has a market cap of Rs 61,940 crore. Divi's Labs is the largest of the group. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on steady 5-year gainer stocks.\"}},{\"@type\":\"Question\",\"name\":\"What are the risks of investing in steady 5-year gainer stocks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Divi's Labs trades at a PE of 82.05 against an industry PE of 36.42, so earnings growth needs to hold up.\"}},{\"@type\":\"Question\",\"name\":\"Why is Divi's Labs trading at a PE of 82.05?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Divi's Labs' PE of 82.05 compares with an industry PE of 36.42. The market is paying a premium for a return on equity of 15.32% and latest-quarter profit growth of 65.50%, which also means the stock is more sensitive if growth slows. Investors in steady 5-year gainer stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.\"}},{\"@type\":\"Question\",\"name\":\"How much do institutions hold in Divi's Labs, Apollo Hospitals, Lodha Developers and Oberoi Realty?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"As of the latest reported quarter, FII and DII together hold 39.55% of Divi's Labs (20.38% and 19.17%), 65.25% of Apollo Hospitals (43.18% and 22.07%), 27.22% of Lodha Developers (23.65% and 3.57%) and 29.94% of Oberoi Realty (15.11% and 14.83%). Rising institutional holding is a useful signal in steady 5-year gainer stocks, though it should be read with earnings trends rather than on its own.\"}}]}<\/script><\/p>\n","protected":false},"excerpt":{"rendered":"<p>4 top steady 5-year gainer stocks compared on market cap, PE, ROE, growth and institutional holding: Divi&#8217;s Labs, Apollo Hospitals, Lodha Developers and Oberoi Realty.<\/p>\n","protected":false},"author":33,"featured_media":318466,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[845],"tags":[13643,13642],"class_list":["post-318467","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-best-stocks","tag-steady-5-year-gainer-sector","tag-steady-5-year-gainer-stocks"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["318466"],"rank_math_title":["Steady 5-Year Gainer Stocks 2026: Divi's Labs, Apollo Hospitals"],"rank_math_description":["Steady 5-year gainer stocks to watch for multibagger potential: Divi's Labs, Apollo Hospitals, Lodha Developers and Oberoi Realty. Compare market cap, PE, ROE and growth."],"rank_math_focus_keyword":["steady 5-year gainer stocks"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/10\/4-top-steady-5-year-gainer-stocks-to-watch-for-future-multibagger-potential-divi.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/318467","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/33"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=318467"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/318467\/revisions"}],"predecessor-version":[{"id":318468,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/318467\/revisions\/318468"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/318466"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=318467"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=318467"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=318467"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}